Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

World Health Organization, 2011 Johnston, 2009, Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis, PLoS One, 4, e6914, 10.1371/journal.pone.0006914 Orenstein, 2009, Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis, Lancet Infect Dis, 9, 153, 10.1016/S1473-3099(09)70041-6 World Health Organization, 2008 Nathanson, 2006, Multidrug-resistant tuberculosis management in resource-limited settings, Emerg Infect Dis, 12, 1389, 10.3201/eid1209.051618 Gammino, 2011, Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects, Int J Tuberc Lung Dis, 15, 1315, 10.5588/ijtld.10.0221 World Health Organization, 2000 Laserson, 2005, Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis, Int J Tuberc Lung Dis, 9, 640 World Health Organization, 2010 Waitt, 2011, A systematic review of risk factors for death in adults during and after tuberculosis treatment, Int J Tuberc Lung Dis, 10.5588/ijtld.10.0352 Holtz, 2006, Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome, Ann Intern Med, 144, 650, 10.7326/0003-4819-144-9-200605020-00008 Leimane, 2005, Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study, Lancet, 365, 318, 10.1016/S0140-6736(05)17786-1 Migliori, 2008, Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?, Eur Respir J, 31, 904, 10.1183/09031936.00159807 Jakubowiak, 2007, Social support and incentives programme for patients with tuberculosis: experience from the Russian Federation, Int J Tuberc Lung Dis, 11, 1210 Bloss, 2010, Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004, Int J Tuberc Lung Dis, 14, 275 Nathanson, 2004, Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative, Int J Tuberc Lung Dis, 8, 1382 Shin, 2007, Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia, Int J Tuberc Lung Dis, 11, 1314 The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Specific treatment parameters and treatment outcomes of multidrug-resistant tuberculosis: an individual patient data (IPD) meta-analysis of 9153 patients, in preparation. World Health Organization, 2011